Rilpivirine

A non-nucleoside reverse transcriptase inhibitor.

Phase of research

Potential treatment - theoretical effect

How it helps

Antiviral

Drug status

Used to treat other disease

1
Supporting references
0
Contradictory references
2
AI-suggested references
0
Clinical trials

General information

Rilpivirine on Pubchem


Marketed as

EDURANT; ODEFSEY

 

Structure image - Rilpivirine

CC1=CC(=CC(=C1NC2=NC(=NC=C2)NC3=CC=C(C=C3)C#N)C)/C=C/C#N


Supporting references

Link Tested on Impact factor Notes Publication date
The potential of Paritaprevir and Emetine as inhibitors of SARS-CoV-2 RdRp
RdRpol Small molecule In silico
in silico 2.80

Predicted to inhibit the SARS-CoV-2 RNA-dependent RNA polymerase.

Dec/02/2020

AI-suggested references